Refractory Peripheral T-Cell Lymphoma
6 clinical trials · Condition
◉ Watch Refractory Peripheral T-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of Brentuximab Vedotin in Patients With R/R PTCL Treated With Gemcitabine (NCT03496779) | The Lymphoma Academic Research Organisation | 2018-04-10 |
| A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL (NCT03349333) | Mundipharma (China) Pharmaceutical Co. Ltd | 2015-09-10 |
| Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies (NCT02106650) | Acrotech Biopharma Inc. | 2014-07-01 |
| Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (NCT01482962) | Millennium Pharmaceuticals, Inc. | 2012-06-11 |
Track Refractory Peripheral T-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.